ESR2 and breast cancer: Independently of ER-α status, the results from our prospective study demonstrate that ER-β- positive BC treated with anastrozole and tamoxifen presents a significant reduction in Ki67 expression after neoadjuvant short-term treatment compared with placebo and ER-β-negative cases.